Lea Harrington

Professor & Chair

University of Toronto
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

To probe drug mechanism of action (MOA) and interrogate the genetic architecture of human cells, we carried out isogenic genome-wide CRISPR/Cas9 knockout screens against 310 diverse drugs, bioactive compounds, and stress conditions. Stringent statistical correction for gene knockout fitness defects yielded a large-scale matrix of >12,000 high confidence chemical-genetic interactions (CGIs). This dataset revealed many previously unappreciated off-target effects for well-characterized compounds and novel MOAs for uncharacterized compounds. The CGI matrix uncovered dense genetic modules that yielded new biological insights into phospholipidosis, mitotic regulation, metabolism, the DNA damage response, and mTOR signaling. The dataset allowed identification of multi-drug sensitization and resistance mechanisms, inference of gene function, elaboration of cross-process connectivity, evaluation of the cell type specificity of CGIs, prediction of chemical synergism, and extensive annotation of understudied genes. This resource provides a map of the genetic landscape in human cells and a framework to help guide drug discovery.

Year:

2026

Telomere maintenance is essential for maintaining genome integrity in both normal and cancer cells. Without functional telomeres, chromosomes lose their protective structure and undergo fusion and breakage events that drive further genome instability, including cell arrest or death. One means by which this loss can be overcome in stem cells and cancer cells is via re‐addition of G‐rich telomeric repeats by the telomerase reverse transcriptase (TERT). During aging of somatic tissues, however, insufficient telomerase expression leads to a proliferative arrest called replicative senescence, which is triggered when telomeres reach a critically short threshold that induces a DNA damage response. Cancer cells express telomerase but do not entirely escape telomere instability as they often possess short telomeres; hence there is often selection for genetic alterations in the TERT promoter that result in increased telomerase expression. In this review, we discuss our current understanding of the consequences of telomere instability in cancer and aging, and outline the opportunities and challenges that lie ahead in exploiting the reliance of cells on telomere maintenance for preserving genome stability.

Year:

2022

Collaborators (15)

Sylvain Meloche

Principal Investigator

Université de Montréal

CANADA
View details

John Aitchison

University of Washington

UNITED STATES
View details

Damien D’Amours

University of Ottawa

CANADA
View details

Vincent Archambault

Université de Montréal

CANADA
View details

Sandhya Manohar

Junior Group Leader

University of Zurich

SWITZERLAND
View details

Philippe Roux

Scientific Director

Université de Montréal

CANADA
View details

Benjamin Kwok

Associate Professor

University of Nebraska Medical Center

UNITED STATES
View details

Katherine L B Borden

Professor

Northwestern Medicine

UNITED STATES
View details

Mike Tyers

Senior Scientist

Hospital for Sick Children

CANADA
View details

Sylvie MADER

Professor

Université de Montréal

CANADA
View details

E. Elizabeth Patton

Chair of Functional and Translational Genomics

University of Edinburgh

UNITED KINGDOM
View details

Trang Hoang

Full professor

Université de Montréal

CANADA
View details

Pierre Thibault

Professor and Principal investigator

Université de Montréal

CANADA
View details

Guy Sauvageau

Professor of Medicine

Université de Montréal

CANADA
View details

Peter B. Dirks

-

CANADA
View details